0730
- Admit to the surgical floor
- Dextrose 59% and 0.9% sodium chloride to infuse at 125 ml/hr
- Advance diet as tolerated
- Insulin glargine 12 units subcutaneous every 12 hours
- Ceftriaxone 2 g IV every 24 hours for 3 days, first dose given in surgery
- Insulin lispro 1 unit subcutaneously per 15 carbohydrates
- Insulin lispro sliding scale:
180-240 mg/dL (10-13.3 mmol/L)- 1 unit
241-300 mg/dl. (13.4-16.7 mmol/L)-2 units
300-360 mg/dL (16.7-30 mmol/L)-3 units
over 360 mg/dL (30 mmol/L)-call the physician
- Glucagon 1 syringe subcutaneously for blood glucose less than 60 mg/dL (3.3 mmol/L) and unresponsiveness
It is 1800, and the client has a schedule dose of insulin glargine due. The client has a regular diet tray ordered with 60 carbohydrates. The tray has not yet arrived in the room.
For each nursing action below, click to specify If the action is indicated, contraindicated or non-essential.
Restart the IV fluids until the tray arrives
Give insulin lispro 4 units
Verify that the client can count carbohydrates
Give insulin glargine 12 units
Mix the insulin lispro and insulin glargine in one syringe
The Correct Answer is {"A":{"answers":"C"},"B":{"answers":"B"},"C":{"answers":"A"},"D":{"answers":"A"},"E":{"answers":"C"}}
Actions:
- Restart the IV fluids until the tray arrives
Non-essential: Restarting IV fluids is not essential while waiting for a regular diet tray. It's more important to ensure the client receives the correct insulin dose when the meal arrives.
- Give insulin lispro 4 units
Contraindicated: Giving insulin lispro before the client has eaten is contraindicated, as it may lead to hypoglycemia without adequate carbohydrate intake.
- Verify that the client can count carbohydrates
Indicated: Verifying the client's ability to count carbohydrates is essential to ensure they can accurately determine the insulin lispro dose when the meal arrives.
- Give insulin glargine 12 units
Indicated: Giving the scheduled insulin glargine dose as ordered is indicated, provided the client has a regular diet tray ordered with 60 carbohydrates.
- Mix the insulin lispro and insulin glargine in one syringe
Non-essential: Mixing insulin lispro and insulin glargine in one syringe is not typically necessary and may increase the risk of dosing errors. Administering them separately using the appropriate syringes is a safer practice.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is A
Explanation
Before administering the first dose of a broad-spectrum antibiotic to a client with a gram-negative infection, it is most important for the nurse to implement:
A. Wound and blood specimens for culture and sensitivity.
Explanation: Collecting wound and blood specimens for culture and sensitivity is crucial before starting antibiotic therapy. This step allows healthcare providers to identify the specific pathogen causing the infection and determine its sensitivity to various antibiotics. It helps in selecting the most appropriate antibiotic and ensuring effective treatment. This is especially important in cases of gram-negative infections, as antibiotic resistance patterns can vary among different strains.
Why the other choices are not the most important at this stage:
B. Irrigation and topical antibiotic application to wound area:
While wound care is important, especially for localized infections, collecting specimens for culture and sensitivity takes precedence to determine the appropriate antibiotic treatment.
C. Complete blood count and serum electrolytes:
While monitoring blood counts and electrolytes is essential in overall client care, it may not be the most critical step before administering the first dose of an antibiotic to address a suspected infection.
D. Monitor for signs of sodium and fluid retention:
Monitoring for signs of sodium and fluid retention is important, but it is not the primary action needed before initiating antibiotic therapy for a gram-negative infection. Identifying the causative organism and selecting the appropriate antibiotic should come first to target the infection directly.
Correct Answer is C
Explanation
A. Serum glucose level of 120 mg/dL (6.7 mmol/L):
This glucose level is within the reference range and is not directly related to the effectiveness of sodium polystyrene sulfonate in treating hyperkalemia.
B. Serum ammonia level of 30 Mcg/dL (17.62 Mamal /dL):
Serum ammonia levels are not typically affected by sodium polystyrene sulfonate, and this value is within the reference range.
When administering sodium polystyrene sulfonate to a client with acute kidney injury (AKI), the medication is used to help lower elevated potassium levels (hyperkalemia). Therefore, the laboratory finding that indicates the medication has been effective is:
C. Serum potassium level of 3.8 mEq/L (3.8 mmol/L).
Explanation: Sodium polystyrene sulfonate is a medication used to treat hyperkalemia by exchanging sodium ions for potassium ions in the intestines, leading to the removal of excess potassium from the body through the stool. A reduction in the serum potassium level within the reference range (3.5 to 5.0 mEq/L) indicates that the medication has been effective in lowering the elevated potassium level associated with AKI.
D. Hemoglobin level of 13.5 g/dl (135 g/L):
Hemoglobin levels are unrelated to the effectiveness of sodium polystyrene sulfonate in treating hyperkalemia. This hemoglobin level is within the reference range.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.